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A single intracerebral injection of tetanus toxin (TeTox) is able to produce a time-dependent translocation of Ca2+-phosphatidylserine-dcpendent 
protein kinase C (PKC) in close-to-term rat brain. TeTox-triggered translocation of PKC is dose- and time-dependent, can be prevented by tetanus 
antitoxin, and does not occur upon administration of toxin fragments B and C. TeTox-triggered PKC translocation is accompanied by a time- 
dependent increase in brain serotonin (S-HT). Increase of brain 5-HT is independent of monoamine oxidaae inhibition by pargyline. Phorbol ester 
and TeTox cause a significant increase in serotonin while H-7, a kinase inhibitor, does not affect serotonin levels but abolishes the effect of TeTox. 
Gangliosides prevent TeTox-triggered 5-HT increase. The data are consistent with the possibility that TeTox acts effectively on the serotonergic 
innervation, presumably in conjunction with PKC to cause accumulation of serotonin. 
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1. INTRODUCTION Ca2+-dependent K+-stimulated 
release process [ 131. 
Tetanus toxin is probably the oldest neurotoxin 
recorded in humans and still a most serious health pro- 
blem in some underdeveloped countries [l]. In spite of 
extensive research carried out for nearly 3 decades 121, 
little information is available about the molecular 
m~ha~srn underlying its toxicity, or the nature of the 
target(s) implicated in its retrograde axonal transport, 
synaptic traverse and inte~~ization in vivo [3-51. 
TeTox is composed of a heavy chain (100 kDa) and a 
light chain (50 kDa) held together by a disulfide bond 
[6,7]. Moderate proteolytic cleavage by papain, results 
in two nontoxic fragments [8] of molecular mass 
45 kDa (fragment C) and 100 kDa (fragment B). 
In our search for a possible molecular target to ac- 
count for the in vivo action of the toxin, we have 
recently reported a TeTox-dependent ranslocation and 
down-regulation of protein kinase C (141. Likewise we 
have shown that TeTox causes an increase of serotonin 
synthesis in the central nervous system [ 151. In this 
report we present evidence suggesting that PKC 
translocation and serotonin accumulation predate the 
clnical symptoms and neurotoxicity, and may be two 
closely associated phenomena. 
The strong affinity of TeTox towards the nervous 
tissue has been attributed to a binding component 
which consists of a disialo- or trisialoganglioside 191. 
Nevertheless gangliosides represent probably only one 
constituent of a more complex receptor which, upon in- 
teraction with the toxin causes intern~ization of the 
latter &IO-121 and/or a blockade of a 
2. MATERIALS AND METHODS 
2.1. Tetanus toxin 
Highly purified tetanus toxin preparations were kindly provided by 
Dr W. Habig (Laboratory of Bacterial Toxins, FDA, Bethesda, MD) 
and Dr C. Montecucco (University of Padova). The solutions con- 
tained approximately 10’ mouse lethal doses (MLD)/mg toxin and 
showed one band on SDS gel ei~rophoresis under nonr~ucing con- 
ditions, as previously described [16]. 
2.2. Animal manipulation 
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GMl, galactosyl-N-acetylgalactosaminyl-(N-acetylneuraminyl)- 
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aminyl-(N-acetylneuraminyl-N-acetylneur~inyl)g~a~osyl~ucosyl- 
cerasnide; BBG, bovine brain ganglioside mixture; TPA, It-O-tetra- 
d~~oyl”phorbol-13-acute; PKC, Ca**-phosphatidylserine- 
dependent protein kinase C; TeTox, tetanus toxin 
Gravid albino rats (Wistar strain) at 20 days gestation were lightly 
anesthetized by intramuscular injection of 0.1 ml/200 g of body 
weight of a mixture (1: 1 v/v) of ketamine (25 mg/kg; Parke-Davis, 
UK) and Rumpon 2% (Bayer, FRG). An abdominal midline incision 
was performed and the uterine horns exposed. 
Tetanus toxin, in 2~41 Pi/saline buffer was injected with a 
Hamilton syringe (10 ~1) by passing through the uterine wall toward 
the fetal brain skull to a point 1 mm below the fontanella and 3 mm 
deep, into the ventricle. A similar injection protocol without 
anesthesia was carried out using neonatal rats. As indicated, TPA, 
H-7 (Sigma, St. Louis, MO), gangliosides (Fidia Res. Lab., Abano 
PubIkbed by Eisevier Science Pub&hers B. V, (Biomedicai Division) 
~145793/90/%3.50 0 1990 Federation of European Biochemical Societies 
neurotransmitter 
61 
Volume 263, number 1 FEBS LETTERS April 1990 
Terme, Italy), tetanus antitoxin (Sclavo, Wayne, NJ) or TeTox 
fragments B and C (Calbiochem) were injected by the same route in 
2 ~1 final volume. 
After treatment, fetuses were returned to the abdominal cavity and 
at desired times were delivered, resuscitated, and killed by decapita- 
tion. Brains were rapidly removed and immediately subjected to fur- 
ther analysis. Administration of pargyline (Sigma, St. Louis, MO) 
was done by intraperitoneal injection. 
2.3. Protein kinase C analysis 
Brain tissue was homogenized with a Polytron apparatus using 
9 vols of buffer consisting of 20 mM Tris-HCl, pH 7.5, 2 mM ED- 
TA, 0.5 mM EGTA, 2mM dithiothreitol, 2mM 
phenylmethylsulphonylfluoride, and 10 PI/ml leupeptin, aprotinin, 
and pepstatin A. The homogenate was centrifuged at 100000 X g for 
1 h, to obtain both soluble and particulate fractions. The latter was 
resuspended to the original volume using the buffer as above, to 
which 0.3% Triton X-100 (final concentration) was added. After 1 h 
incubation at 4”C, the Triton X-lOO-treated particulate fraction was 
centrifuged at 100000 x g for 1 h, to obtain the Triton X-100 soluble 
fraction [17]. Each of the ensuing supernatants was mixed with a 
slurry of DEAE-cellulose (0.75 ml) and after shaking for 15 min, 
samples were centrifuged for 1 min at 20000 x g in an Eppendorf 
microfuge. The supernatant was discarded and pellet washed 4 times 
with 0.75 ml of buffer containing 20 mM NaCl in 20 mM Tris-HCl, 
pH 7.5, and 2 mM EDTA, 0.5 mM EGTA, 2 mM dithiothreitol and 
0.1% Triton X-100. Elution of PKC was accomplished at 4°C by two 
consecutive lutions, 0.5 ml each, of the above buffer supplemented 
with 200 mM NaCI. PKC was assayed in the presence of 0.04% 
Triton X-100 by measuring the incorporation of 32P from 
[Y-~*P]ATP into lysine-rich histone (type III-S; Sigma, St. Louis, 
MO), as previously described [171. Total PKC activity represents the 
combined activity of the soluble and detergent-extracted particulate 
fraction each determined independently and normalized per wet 
weight. Protein was determined according to Bradford [18]. 
2.4. Serotonin determination 
Toxin-treated or untreated rat neonates were sacrificed by 
decapitation and whole cerebral hemispheres were excised and rapid- 
ly homogenized in 9 vols of 74% ethanol in water. The serotonin was 
extracted according to a published procedure [15] using a column 
containing a 0.4 x 2.5 cm Amberlite CG-50 (H+, type II, 200-400 
mesh, Prolabo) resin bed. The biogenic amines were retained at 
neutral pH and subsequently eluted with 5 ml of 0.2 N acetic acid. 
Serotonin was quantified by a fluorescent procedure described 
elsewhere [19]. Essentially similar results were obtained upon ex- 
amination of close-to-term fetuses. All reagents used were of 
analytical grade. 
3. RESULTS 
A single intraventricular injection of 40 MLD of tox- 
in produces a marked intracellular redistribution of 
PKC activity in the neonatal brain. As shown in Fig. 1, 
a substantial portion of PKC is translocated after 1 h 
from the cytosol to the membrane compartment. The 
reduction in activity in the soluble fraction, which 
amounted to about 2%35070, isentirely recovered in the 
membrane fraction suggesting that no apparent down- 
regulation of the enzyme occurred. Intraperitoneal in- 
jection of the TPA phorbol ester, produces an identical 
pattern of translocation as is also depicted in Fig. 1. 
The TeTox-induced translocation is time-dependent, as 
is illustrated in Fig. 2A. After 15 min and 30 min ex- 
posure, 38% and 44% of the enzyme activity, respec- 
tively, is associated with the membrane fraction 
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Fig. 1. Tetanus toxin and phorbol ester (TPA)-induced translocation 
of Ca*‘-phosphatidylserine-dependent protein kinase C. Rat 
neonates injected either intracerebrally with tetanus toxin 
(40 MLD/rat) in 2~1 medium (hatched bars) or intraperitoneally 
with 25 pl of 25 CM TPA solution (15 pmol/g body weight, 1.5 x 
lo-’ M) (open bars), were killed after 1 h or 10 min, respectively. 
Two separate groups of control animals were injected similarly with 
the corresponding vehicle, for the same time. Value given after the 
intracerebral injections of the vehicle (closed bars) was statistically 
comparable, to the intraperitoneal-sham-treated group. Values are 
expressed as per cent of total PKC activity. The total enzyme activity 
in the neonatal brain ranged between 200 and 250 U/mg protein. 
Each bar represents the mean + SD of 3-5 individual animals. 
Student’s t-test was used for calculating probability, which was 
significant (* P < 0.005). 
compared to 31% in sham animals. By 60 min the en- 
zymatic activity in the membrane fraction is doubled. 
The unique feature of TeTox in inducing translocation 
can be further appreciated from Fig. 2B, which clearly 
shows that even a limited dose (0.2 MLD) of TeTox can 
produce a significant effect on PKC distribution. The 
specificity of the toxin has been studied to some detail. 
First, as shown in Fig. 3, it is evident that the entire 
TeTox molecule is required in order to produce PKC 
activation. Second, neither fragment B which contains 
the toxic (albeit inactive) site [20], nor fragment C 
which contains the binding site, are able to produce 
translocation even at concentrations which are lOO-fold 
greater than those used with TeTox. Premixing of the 
toxin with anti-TeTox, before application also entirely 
prevents the effect. 
The question of neurotransmitter presynaptic 
specificity and the exact nature of the general impair- 
ment of neuronal circuits caused by intracerebral ad- 
ministration of tetanus neurotoxin is still an unresolved 
problem. Certain central symptoms of tetanus such as 
insomnia, parkinsonism, hyperthermia and hyperten- 
sion seem to involve different monoaminergic systems 
[3]. In addressing this issue we were recently able to 
demonstrate, using adult rats, that of the various brain 
biogenic amines tested, serotonin exhibited the highest 
rise after intraventricular TeTox application [ 15,191. 
Since serotonergic innervation is one of the first to ap- 
pear during brain ontogeny [21] it was appropriate to 
investigate the levels of this biogenic amine following 
toxin administration during the perinatal phase of 
development. 
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Fig. 2. Time- (panel A) and dose- (panel B) dependent protein kinase 
C translocation with a single intracerebral application of tetanus 
toxin. Intracerebral injection of 20 MLD (A) or varying doses (B) of 
tetanus toxin was performed in 2 ~1 volume as described in section 2. 
Animals (3/group) were killed at times designated (A) or after 1 h (B) 
exposure to the toxin and PKC activity (100-150 mU/mg protein) 
determined. The values expressed as percent activity are mean * SD. 
The results analyzed using a Student’s t-test were found significantly 
different between control and 20 min (20 MLD), and control and 2 
and 20 MLD (panel B) for both soluble and membrane-bound PKC 
activities. The variance analysis of the means (one-way ANOVA) are 
also significant in all 4 groups (P < 0.005). 
Fig. 4. Time- (panel A) and dose- (panel B) dependent 
5hydroxytryptamine accumulation after a single intracerebral 
application of tetanus toxin. Experimental details are essentially as 
detailed in Fig. 2, except hat 7.5 MLD were used for the time course. 
The values expressed as nmol/g tissue it SE were obtained from 3-4 
animals. 
As seen in Fig. 4, the increase in 5-hydroxy- 
tryptamine (5-HT) after intracerebral injection of 
TeTox (7.5 MLD) is time-dependent and linearly in- 
creases from a value of 2.28 f 0.12 to a value of 3.37 + 
0.17 nmol/g brain after 1 h. This value can be obtained 
by injection of 2 MLD for 1 h but did not increase 
when 100 MLD or higher doses were injected. 
In order to better understand the mechanism 
underlying the toxin-mediated serotonin increase, 
pargyline, the inhibitor of monoamine oxidase (MAO), 
was utilized [22]. Fig. 5 illustrates the changes in the 
levels of serotonin after administration of 5 MLD of 
TeTox. The data clearly show that serotonin is increas- 
ed after 1 h in the presence of the toxin. Fig. 5 also 
shows that intraperitoneal administration of pargyline 
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Fig. 3. Effect of toxin fragments and tetanus antitoxin on protein 
kinase C translocation. Rat neonates (3-4 per group) were injected 
and maintained for 1 h with nontoxic preparations of fragment B 
(0.5 pg protein/rat), fragment C (0.5 cg protein/animal) or with 
40 MLD/animal in the absence or presence of excess amounts of 
equine antitoxin (administered by the same route). Values expressed 
as mU/mg protein are mean with a standard deviation of less than 
10%. Student’s t-test used to calculate probability in tetanus toxin 
treated animals was statistically significant with respect o the control 
or antitoxin groups (* P C 0.05). 
Fig. 5. Serotonin levels after tetanus toxin administration in the 
presence of pargyline. A single dose of TeTox (5 MLD) was given to 
2-day-old rats by the intracerebral route in the absence or presence of 
pargyline (parg) given intraperitoneally (75 mg/kg) in 25 ~1 of 
Pi/saline buffer. After 1 h the animals (4-6 per group) were 
decapitated and serotonin determined as described in section 2. The 
results expressed as nmol/g brain + SE were statistically significant 
using the Student’s f-test. 
63 
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Table I 
Levels of 5hydroxytrypamine in toxin-treated animals after exposure 
to various agents 
Stock solution 5-HT nmol/g brain wet weight 
Saline Tetanus 
(5 MLDlanimal) 
Saline 2.09 4 0.04 2.92 f 0.23* 
Fragment B (0.25 mg~‘ml) 2.10 f 0.05 N-D. 
Fragment C (0.25 mgfml) 2.21 f O.f7 N.D. 
GM1 (1 mgfml) 2.19 f a&P 2.53 2 0.09* 
GDlb (1 mg/ml) 2.09 f 0.17 1.68 f O.W* 
BBC (1 mg/ml) 1.92 f 0.14 1.85 f 0.14** 
TPA (2 mg/ml) 2.53 rs: o.a7* N.D. 
H-7 (0.1 mg/ml) 2.17 f 0.15 2.05 f 0.21** 
Anti-TeTox (1 U/ml) N.D. 2.08 f O.OO+* 
The experiment was carried out essentially as detailed in Fig. 4, 
except hat all compounds prepared at the noted concentrations were 
delivered by the intracerebral route in 2 ~1 final volume. Each value 
represents the mean f SEM of 4-f animals. Statistical evaluation 
(F < 0.05) between groups was determined by the Student’s t-test 
with respect o naive ~~ne/~ine~ group (*) or toxin-treated ($4 
group. N.D. not determined 
increases the levels of serotonin above the control 
values as expected from a compound which prevents 
degradation of biogenic amines in general [23]. In- 
terestingly, serotonin levels continue to rise significant- 
ly from 2.28 f 0.07 to 5.29 f 0.7 am&g brain, when 
both TeTox and pargyline are administered con- 
comitantly intraventricularly and intraperitoneally, 
respectively, into the animal. 
The effect of TeTox on the levels of serotonin is 
highly specific as empha~z~ by a number of agents, 
the effects of which are summarized inTable I. In line 
with the lack of PKC tr~slocation/activation, dif- 
ferent fragments of tetanus toxin do not produce any 
considerable ffect on serotonin levels. Furthermore, 
TeTox-induced serotonin increase is not seen in the 
presence of antitoxin and is prevented by the coad- 
ministration of GDlb or a mixture of bovine brain 
gangliosides and TeTox. The effect of GM1 may relate 
ta its ability to bind TeTox in certain conditions [24]. 
Finally TPA, the specific activator of PKC, produces 
an increase in serotonin level while intracerebral d- 
ministration of the H-7 kinase inhibitor abolishes 
TeTox-triggered serotonin accumulation as expected 
from a metabolic sequence which may involve protein 
kinase C [25]. 
4, DISCUSSION 
In a recent study we have provided substantial 
evidence indicating that a single intraventricular injec- 
tion of TeTox causes in the adult rat brain a marked ac- 
tivation followed by a down-regulation f PKC f 14] I In 
a similar manner, we now demonstrate that a single 
dose of toxin as low as 0.2 MLD injected intracerebral- 
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ly into the close-to-term or the neonatal rat causes 
within 15-30 min a substantial translocation of brain 
PKC. Under these experimental conditions, there are 
na behavioral changes in the animals and no signs of 
neurotoxicity, making remote the possibility of seizures 
as a reason for PKC translocation. In this context it is 
notable to recall that according to the definition, 
1 MLD is the minimal mount of toxin necessary tokill 
a 20 g mouse in 4 days ]16]. Thus, tra~lo~tion of 
PKC takes place at subn~o~~ levels of toxin, This 
is to our knowledge the lowest level of toxin recorded 
which elicits a measurable biochemical response in 
tetanus. Furthermore, TeTox-triggered translocation is
highly specific since papain digests of the toxin (e.g. 
fragments B and C) do not cause this effect and an an- 
titoxin serum can prevent ranslocation. 
The present data indicate that TeTox-triggered 
translocation of PKC is very similar to that obtained 
after intraperitoneal dministration of the tumor pro- 
motar phorbol ester TPA, The effect of TPA occurs in 
vivo within 10 min pr~umably due to the rapid 
distribution of the li~phyli~ drug through the fetal 
organs. However, unlike the phorboi ester which acts at 
nanomolar concentration and is not selectively targeted 
to neuronal membranes, the TeTox-triggered PKC ac- 
tivation is highly specific to brain tissue. 
The main thrust of this work has been to identify and 
characterize a possible heuxotransmitter-target 
system(s) which may be affected at the time TeTox- 
triggered translocation/activation of PKC takes place. 
Biogenic amines, particularly serotonin, appeared to us 
as a potential candidate in the light of our previous 
studies, indicating an elevation of serotonin in the adult 
rat brain following intraventri~ul~ application of 
TeTox [l&19]. The developing brain was found suit- 
able for these studies since it contains already fairly 
high levels of biogenic amines [2X,26,30] including 
serotonin (i.e. 66% of the maximal adult values (see 
[19])). Furthermore the perinatal model was advan- 
tageous for the following reasons: first, administration 
of tbe toxin to the neonates did not require anesthetic 
procedures which may interfere with the translocation 
particularly during short-term studies. Second, the 
generalized symptoms of tetanus toxicity seen in the 
adult are practically nonexistent in the rat neonate 
perhaps because of an overall simplified neuronal cir- 
cuitry, which does not induce secondary focal seizures. 
Evidently the early signs of spontaneous electroence- 
phalographic activity in the rat appears first at 10 days 
postnatally [27]. 
After administration of the toxin, a time-dependent 
and dose-dependent change in the levels of serotonin is 
clearly evident. Accumulation of serotonin is in line 
with the general dogma that TeTox acts at presynaptic 
terminals to inhibit release of certain neurotransmit- 
ters, including excitatory ones [3,7]. Nevertheless, the 
additive effect of pargyline and TeTox on serotonin 
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levels (Fig. 5) indicates that the toxin affects the 
serotonergic system, perhaps through a second 
mechanism, i.e. the activation of t~tophan-5-mono- 
oxygenase. Phosphorylation of this enzyme by a cal- 
modulin-dependent reaction has been indicated [28,29]; 
a protein kinase C-dependent activation has not been 
excluded. It is conceivable that TeTox may trigger 
tryptophan-5-monooxygenase phosphorylation by ac- 
tivating such a kinase, as much as it can act by in- 
hibiting serotonin release. 
The present findings indicate that PKC activation 
and serotonin accumulation may be closely related, 
based on the following arguments: first, TeTox causes 
PKC activation at extremely low doses, which is accom- 
panied by a time- and don-de~ndent S-HT accumula- 
tion. Second, addition of antitoxin prevents 
TeTox-triggered PKC translocation, as well as ac- 
cumulation of serotonin. The latter is also reduced in 
the presence of GDlb, the putative TeTox receptor. 
Third, TPA causes an increase in serotonin levels which 
strongly indicates a PKC-me~ated response. A similar 
relationship has been established in brain slices sub- 
jected to phorbol esters [30,31]. Finally, H-7 prevents 
as expected from a protein kinase inhibitor the TeTox- 
triggered serotonin accumulation. 
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